Apimeds Pharmaceuticals US (APUS) Times Interest Earned (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) reported Times Interest Earned of -$32.65 for Q4 2025, down 327.06% on a YoY basis from $14.38 in Q4 2024, and up 88.84% quarter-over-quarter from -$292.69 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Times Interest Earned (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US has reported Times Interest Earned for 2 years, with the latest figure at -$32.65 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned fell 327.06% year-over-year to -$32.65; the trailing twelve-month figure through Dec 2025 stood at -$42.09 (down 288.6% YoY), and the FY2025 full-year result was -$42.09, down 288.6% from the prior year.
- Times Interest Earned for Q4 2025 stood at -$32.65, up from -$292.69 in the prior quarter.
- The five-year high for Times Interest Earned was -$7.65 in Q4 2024, with the low at -$292.69 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Apimeds Pharmaceuticals US | 13.93 Mn | 10.29 Mn | - | -32.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32.65 |
| Sep 30, 2025 | -292.69 |
| Jun 30, 2025 | -115.55 |
| Mar 31, 2025 | -9.58 |
| Dec 31, 2024 | -7.65 |
| Sep 30, 2024 | -9.19 |
| Jun 30, 2024 | -19.34 |
| Mar 31, 2024 | -10.10 |